Literature DB >> 8373158

Ischemia/reperfusion-induced injury of forebrain mitochondria and protection by ascorbate.

M A Sciamanna1, C P Lee.   

Abstract

Complete, reversible forebrain ischemia was induced with a seven-vessel occlusion rat model. Previous studies of ischemic (M. A. Sciamanna, J. Zinkel, A. Y. Fabi, and C. P. Lee, 1992, Biochim. Biophys. Acta 1134, 223-232) rat brain mitochondria (RBM) showed that ischemia of 30 min caused an approximately 60% decrease in State 3 respiratory rates with both succinate and NAD-linked substrates and also in energy-linked Ca2+ transport. No significant change was seen in the State 4 rates. The inhibition of respiration could be prevented by EGTA or ruthenium red. In this paper it is shown that reperfusion (5 h) following ischemia (30 min) further impaired RBM respiratory activities (succinate and NAD-linked substrates). The presence of EGTA or ruthenium red in the assay medium did not protect against ischemia/reperfusion-induced injury. The effects of ascorbate, an oxygen radical scavenger, were studied. RBM isolated from ascorbate-treated animals (0.8 mg ascorbate/kg body weight) after ischemia (30 min) alone showed only a slight increase in State 3 (approximately 25%) and a decrease in State 4 (approximately 20%) activities with succinate, when compared to untreated 30-min ischemic animals, whereas, with glutamate+malate little or no effect was seen. The respiratory activities of RBM from ascorbate-treated, ischemic/reperfused (30 min/5 h) rats were restored to approximately 65% of controls levels. Ascorbate protection was dose-dependent with maximum protection at 0.8 mg ascorbate/kg body weight of rat. The k of succinate oxidase-supported Ca2+ uptake also returned to 62% of control values. Protection by ascorbate was most effective when administered prior to the onset of ischemia and provided partial protection when administered after the onset of reperfusion. These results suggest that ischemia-induced injury is primarily mediated by disruption of cellular Ca2+ homeostasis, and reperfusion-induced injury by peroxidative events.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373158     DOI: 10.1006/abbi.1993.1414

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

Review 1.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

2.  The role of ascorbate in brain: therapeutic implications.

Authors:  J R Smythies
Journal:  J R Soc Med       Date:  1996-05       Impact factor: 18.000

3.  epsilonPKC phosphorylates the mitochondrial K(+) (ATP) channel during induction of ischemic preconditioning in the rat hippocampus.

Authors:  Ami P Raval; Kunjan R Dave; R Anthony DeFazio; Miguel A Perez-Pinzon
Journal:  Brain Res       Date:  2007-10-05       Impact factor: 3.252

4.  Ascorbate compartmentalization in the CNS.

Authors:  M E Rice
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

5.  Early mitochondrial dysfunction after cortical contusion injury.

Authors:  Lesley K Gilmer; Kelly N Roberts; Kelly Joy; Patrick G Sullivan; Stephen W Scheff
Journal:  J Neurotrauma       Date:  2009-08       Impact factor: 5.269

Review 6.  The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q.

Authors:  R E Beyer
Journal:  J Bioenerg Biomembr       Date:  1994-08       Impact factor: 2.945

7.  Mitochondrial calcium transport and mitochondrial dysfunction after global brain ischemia in rat hippocampus.

Authors:  Peter Racay; Zuzana Tatarkova; Maria Chomova; Jozef Hatok; Peter Kaplan; Dusan Dobrota
Journal:  Neurochem Res       Date:  2009-02-28       Impact factor: 3.996

Review 8.  Targeting oxidative stress for the treatment of ischemic stroke: Upstream and downstream therapeutic strategies.

Authors:  Wenjun Li; Shaohua Yang
Journal:  Brain Circ       Date:  2016-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.